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Abstract 
The attention of healthcare providers to the developmental level of adolescent patients 
with type one diabetes (T1D) maximizes effective patient education and glycemic 
control.  Due to the dynamic changes that occur in the mind and body during 
adolescence, self-care for adolescent T1D patients is overwhelming as it envelopes 
activities of everyday life.  The disease process and the unique aspects of adolescence in 
relation to T1D are important for caregivers to consider.  Developmentally appropriate 
teaching during the initial onset of the disease must inform the patient and the patient’s 
family of the basics of the disease process and the daily care necessary for survival.  
Continuous and gradually increasing education is accomplished through regular 
appointments with the healthcare provider as well as through the gradual handing over of 
self-care responsibility from the parent to the adolescent.  The physical and social needs 
of the adolescent should be incorporated into the education for the best results in 
compliance and adherence to the diabetes regimen.  Motivational interviewing (MI) is an 
effective intervention for patients who are entering puberty and who experience increased 
ambivalence toward diabetes self-management. 
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Diabetes Self-Management Education for Adolescent Patients: 
The Importance of a Developmentally Sensitive Approach 
 Type 1 diabetes (T1D) is a disease that affects everyday life.  Management of this 
disease is complex and is best accomplished when the adolescent is an active participant 
in his or her own care (Clement, 1995).  Unfortunately, total self-management is not 
possible for persons at any developmental level during the initial diagnosis (Schiffrin, 
2001).  The goal of diabetes education is to motivate the patient to implement behavioral 
changes that promote tight glycemic control in the initial period and for the long stretch 
(Michel, 2011).  
 In adolescence, children transition into adulthood and experience dramatic 
physical, cognitive, social and emotional changes.  Puberty refers to the initiation of 
reproductive organ functioning along with the accompanying developmental processes 
and secondary sex characteristics.  The period of adolescence begins with the appearance 
of secondary sex characteristics and ends with the completion of physical maturation.  
People experience these phenomena at different times; however, secondary sex features 
generally appear at 11 or 12 years of age and physical growth is often completed by 18 to 
20 years of age (Kollar, 2013).   
 An adolescent with T1D will experience barriers to a healthy lifestyle that relate 
to his or her developmental challenges.  The adolescent period of life is characterized by 
a search for identity (Franklin & Prows, 2013).  Puberty accompanies many physical and 
psychosocial challenges and the adolescent patient needs to continue to develop his or her 
growth despite the presence of chronic illness (Coffen & Dahlquist, 2009).  However, 
these challenges tend to negatively affect blood glucose levels and glycemic control tends 
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to diminish during the transition to adolescence (Christie et al., 2009; Coffen & 
Dahlquist, 2009; Lowes & Fernandes, 2008; Trast, 2014).  Patient education that properly 
assesses the psychological needs of the adolescent will empower the patient to cope with 
diabetes and achieve normal developmental landmarks during this transitional period of 
life (Coffen & Dahlquist, 2009).  Psychological therapy of adolescents with T1D has 
been shown to improve glycemic control (Serlachius et al., 2014), and by extension 
reduce long term complications (The Diabetes Control, 1993). 
 Adolescents are intensely social in their activities.  They are growing more 
independent from parents and moving closer to friends.  Peer groups strongly influence 
adolescent behavior; an adolescent desires to belong to a group and will act in such a way 
as to attain establishment within a group of peers (Kollar, 2013).  Group education can 
enhance compliance and the desire to develop proficiency in their self-care skills.  
Educators can also facilitate normalization by gathering adolescent T1D patients in group 
settings and allowing them to share their experiences, skills, and information.  This 
setting also provides the patients with a sense of belonging and gives them an avenue for 
trying different roles and developing their identities (Docherty, Barfield, Thaxton, & 
Brandon, 2013). 
 The initial education must provide the patient with the basic survival instructions 
so that the patient will avoid life-threatening situations.  Discussing the pathogenesis of 
the disease helps the adolescent understand what is going on inside of his or her body.  
Having an understanding of the disease process also provides a knowledge base for 
understanding the necessity of treatment.  The patient needs to understand the actions and 
purpose of the hormone insulin and the detrimental effects of the lack of insulin 
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production by the pancreas.  It is also important for the educator to provide psychological 
support by explaining to the adolescent that T1D is not necessarily caused by something 
that the patient did or did not do.  The educator must relate the information in terms that 
the patient can understand so that the patient can develop an appropriate concept of the 
disease.  The patient should understand the implications of preprandial and postprandial 
blood glucose levels so that the patient can effectively manage insulin therapy.  
Glycosylated hemoglobin (HgbA1c) readings are telling of the overall glucose levels in 
the past three months and will be emphasized in the patient’s future education (Lange, 
Swift, Pankowska, & Danne, 2014).   
 Insulin is available in multiple forms.  Types of insulin vary and can be tailored to 
the patient’s specific needs; adherence to the insulin regimen should be emphasized 
(Lange et al., 2014).  Acute complications such as diabetic ketoacidosis may occur if 
regular insulin therapy is neglected (Jones, Brashers, & Huether, 2010).  Chronic 
complications result from the effects of hyperglycemia when blood glucose levels are not 
controlled effectively (The Diabetes Control, 1993).   
 Initial patient education also includes information regarding hypoglycemia, 
exercise, and nutrition.  The patient should be introduced to the signs, symptoms, and 
probable causes of hypoglycemia, which can quickly escalate if it is not treated swiftly 
(Lange et al., 2014).  Exercise and nutrition need to be discussed as they relate to changes 
in the blood sugar.  Although the patient should receive initial teaching on exercise and 
nutrition, the teaching should be built up and developed throughout the disease process, 
so the patient does not become overwhelmed and less likely to comply with the regimen 
(Coffen & Dahlquist, 2009).  It is beneficial to emphasize the more pertinent self-care 
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activities with the adolescent and to discuss the nutrition plan and exercise schedule with 
the parent.  The meal plan should be realistic enough for the patient to adhere to it.  Meal 
planning should give attention to the glycemic index of foods and the patient’s blood 
glucose levels in relation to insulin administration for each meal.  When parents of 
adolescents with T1D govern the meal plan, these patients have better clinical outcomes 
(Swift, 2007).  The parent or primary caregiver can then gradually transfer self-care 
activities over to the adolescent in accordance with the adolescent’s readiness for 
increased responsibility and involvement (Roper et al., 2014).  The goal of these efforts is 
the maintenance of tight blood glucose control as blood glucose levels that are 
uncontrolled are associated with increased morbidity in diabetic persons (The Diabetes 
Control, 1993).    
 There are numerous aspects to the management of diabetes.  Covering all of these 
aspects during the first hospital admission is overwhelming for the adolescent and is not 
advised.  Rather, it would be better for the educator to go into realistic depth in a few 
vital areas of self-care and then gradually build up the adolescent’s holistic self-care 
abilities.  Bulk information cannot be immediately absorbed, but life experience provides 
a medium of attachment and retention for further teaching (Coffen & Dahlquist, 2009). 
 Because diabetes education for adolescent patients is much more complex than 
transmission of facts, behavioral modification therapy is indicated (Lange et al., 2014).  
Motivational Interviewing (MI) is a behavioral change technique that is patient-focused 
and helps address the patient’s ambivalence to change.  MI affects change by increasing 
the patient’s awareness of his or her own desire to change and be healthy (Rollnick, 
Miller, & Butler, 2007).  Performing glucose checks, administering insulin, narrow 
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dietary allowances, and monitored physical activity are only a few of the aspects to 
diabetes self-care that can cause the adolescent to feel different and isolated from his or 
her peers.  The distaste for standing out can discourage an adolescent’s self-care practices 
for the sake of achieving peer acceptance (Naar-King & Suarez, 2011).  Addressing the 
patient's barriers to self-care must take place before solutions can be developed.  MI takes 
the stance that people want to be healthy, but the behavioral changes that lead to health 
can seem daunting, which causes resistance to change.  It is not the end goal of being 
healthy that is undesirable, but the journey to get there (Rollnick et al., 2007).  MI 
focuses on building the adolescent’s intrinsic desire to change and achieve a normal life 
(Naar-King & Ellis, 2011).  This technique is sensitive to the patient’s developmental 
level and autonomy and has been found to be an effective intervention for adolescents 
with chronic diseases, such as T1D (Naar-King & Ellis, 2011; Rollnick et al., 2007). 
 When the adolescent is an active participant in his or her own care and when self-
care responsibilities are transferred to the patient gradually, clinical outcomes are better 
(Clement, 1995; Coffen & Dahlquist, 2009).  Healthcare providers should be alert for 
signs of diminished glycemic control in an adolescent because of the known psychosocial 
and physical predispositions of this age group (Christie et al., 2009).  Although 
adolescents are capable of achieving competency in diabetes self-management, 
developmental issues often present barriers to self-care.  For this reason, adolescents 
should receive care that addresses their developmental needs and helps them to overcome 
challenges and attain a healthy lifestyle (Lange et al., 2014).   Simply prescribing 
medications and loading the patient with information are not enough to affect optimal 
health in the adolescent patient.  Research has delineated the necessary self-care activities 
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that diabetes patients should incorporate into their lifestyle for optimal outcomes, and so 
the challenge is to get the patient to put these activities into practice.  MI is a 
developmentally appropriate and effective technique for addressing ambivalence to 
change and for promoting intrinsic motivation for improved diabetes self-care.  
Healthcare providers and adolescents with T1D alike will benefit from the incorporation 
of MI into patient care (Naar-King & Suarez, 2011).  Because of this benefit, 
incorporation of MI into the plan of care for adolescents with T1D should be considered. 
Carbohydrate Metabolism 
 T1D completely alters the metabolism of carbohydrates, the body’s initial source 
of energy.  Carbohydrates are broken down into monosaccharides during digestion and 
then released into the blood stream through the intestinal walls (Swinny, 2013).  Glucose 
is a six-carbon monosaccharide that provides the body with an efficient source of energy 
(Guven, Matfin, & Kuenzi, 2009).   
 Glucose is taken into cells through the effects of insulin.  In a well-oxygenated 
cell, glucose will undergo aerobic glycolysis and yield pyruvate.  Upon entering the 
mitochondria of the cell, pyruvate can then be transformed by pyruvate dehydrogenase 
into acetyl coenzyme A (CoA), which fuels the tricarboxylic acid (TCA) cycle, also 
known as the Krebs cycle or the citric acid cycle.  Through this cycle, pyruvate yields 
carbon dioxide (CO2), three nicotinamide adenine dinucleotide (NADH) molecules, and 
one flavin adenine dinucleotide (FADH2) molecule.  NADH and FADH2 are able to 
donate electrons to the electron transport chain located in the inner membrane of the 
mitochondria.  As electrons are passed down the electron transport chain they lose 
energy.  This energy is captured, in part, by adenosine triphosphate (ATP) when it 
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undergoes oxidative phosphorylation from adenosine diphosphate to ATP.  ATP is a 
high-energy compound that releases approximately 7.3 kcal/mol (30.7 kJ) for each 
phosphate group hydrolyzed.  This is the energy that makes glucose metabolism so 
valuable to the body (Harvey & Ferrier, 2011).   
Insulin 
 Insulin is an anabolic hormone that lowers blood glucose levels.  The precursor of 
insulin, called proinsulin, is a molecule composed of an A peptide, a B peptide, and a C 
peptide.  The beta cells synthesize insulin from proinsulin by cleaving both ends of the C 
peptide from proinsulin, leaving the A and B peptide as the active form of insulin.  
Insulin synthesis in the beta cells is stimulated by parasympathetic activity or increased 
blood levels of glucose, amino acids, free fatty acids, or digestive hormones.  Insulin 
production diminishes in the presence of hypoglycemia, sympathetic stimulation of 
pancreatic alpha cells, and hyperinsulinemia.  Without insulin, glucose cannot permeate 
the cell membrane of the tissues.  Insulin released from the pancreas travels to a tyrosine-
kinase receptor subtype which then triggers phosphorylation of the insulin receptor 
substrate I and of other proteins.  These actions result in the movement of glucose 
transporter (GLUT) proteins to the cell membrane where they act as catalysts of glucose 
intake.  Without GLUT proteins, cellular glucose uptake would be significantly slower 
(Brashers & Jones, 2010; Guven et al., 2009) 
 Insulin also lowers blood glucose levels by promoting the storage of glucose as 
glycogen by the liver.  Insulin inhibits proteolysis by inhibiting gluconeogenesis, the 
formation of new glucose molecules from amino acids and other compounds.  On the 
contrary, protein synthesis is increased in the presence of insulin as insulin stimulates the 
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active transport of amino acids into cells.  Fat metabolism is also affected by insulin.  
Insulin draws glucose into fat cells, allows for triglyceride synthesis from glucose, and 
halts the breakdown of stored triglycerides in the cells (Guven et al., 2009).  
Pathophysiology of Type 1 Diabetes (T1D) 
 T1D is a disease in which the pancreas does not produces insulin due to 
autoimmune destruction of the insulin-secreting beta cells of the pancreas.  There are rare 
cases of idiopathic T1D of which the cause cannot be identified as autoimmune (Guven et 
al., 2009).  For the purposes of this discussion, T1D will be considered an autoimmune 
disease.   
 T1D is the result of the destruction of the beta cells by the body’s own immune 
system.  Therefore, the pathophysiology of T1D is marked by a stimulus that incites 
immune cells against pancreatic beta cells.  The actual trigger varies from person to 
person; however, it involves interplay between genetic predisposition and environmental 
factors.  Major histocompatibility complex (MHC) class II molecule genes in the DR and 
DQ loci are of particular importance in the pathogenesis of T1D.  Human leukocyte 
antigen (HLA)-DQ and HLA-DR are correlated with a risk of T1D that is five to eight 
times higher than the general population.  HLA-DR has been noted to relate to other 
autoimmune disorders as well.  If a person has inherited the HLA-DR3 and the HLA-
DR4 allele from both parents, this individual’s risk of T1D is 20 to 40 times greater than 
average (Jones et al., 2010).   
 Environmental triggers coupled with a genetic predisposition further heighten an 
individual’s likelihood of developing T1D.  Beta cell damage via the immune system has 
been associated with the presence of certain viruses, including congenital rubella, 
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cytomegaloviruses, mumps, and Epstein-Barr virus.  Notably, 40% of individuals 
diagnosed with congenital rubella will develop T1D at some point.  Bovine serum 
albumin which can be found in cow’s milk is thought to be involved in stimulating beta 
cell autoantibodies.  High dietary intake of nitrosamines and exposure to the rodenticide 
Vacor, the chemical alloxan, and the drugs Streptozotocin and Pentamidine are also 
environmental factors that increase the risk of developing T1D (Jones et al., 2010).   
 In the presence of the various genetic and environmental factors, beta cell 
destruction occurs through T-cell mediated inflammation of the islets and autoantibody 
production against islet cells, insulin, and glutamic acid decarboxylase (GAD).  
Pancreatic islet cells present autoantigens on the cell surface that circulate in the blood 
and lymphatics.  Antigen-presenting cells (APCs) detect and ingest these autoantibodies 
and, in turn, stimulate CD4+ T helper lymphocytes to secrete interleukin 2 (IL-2).  IL-2 is 
a cytokine that stimulates the proliferation of beta cell autoantigen-specific T cytotoxic 
CD8 lymphocytes.  These cytotoxic cells secrete granzymes and toxic perforins that 
further damage beta cells.  CD4+ T helper cells also secrete interferon.  Interferon is a 
cytokine that mediates the involvement of other proinflammatory cytokines and activates 
macrophages.  The result is compounding activity against beta cell life (Jones et al., 
2010).   
 The T helper cells that produce IL-2 and interferon to promote inflammation also 
produce interleukin 4 (IL-4), which relates to the development of autoantibodies.  IL-4 
triggers B cell proliferation and antibody production.  Autoantibodies to islet cells, 
insulin, GAD65, and tyrosine phosphatases are found in 85% to 90% of individuals with 
T1D when fasting.  Diminished beta cells can be detected by positive islet cell 
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autoantibodies in the blood years before a patient becomes symptomatic.  This shows the 
slow autoimmune progression that typifies T1D.  Insulin autoantibodies are more likely 
to develop during islet cell destruction.  Thus, T1D develops due to inflammation and cell 
death of islet cells as well as the production of autoantibodies against beta cells, insulin, 
GAD, and other proteins.  This results in the body’s inability to cope with rising blood 
glucose levels (Jones et al., 2010).   
Short-Term Complications 
 Acute complications of T1D can be either hypoglycemic or hyperglycemic in 
nature.  Hypoglycemia can occur if the patient receives too much insulin treatment, 
exercises without extra carbohydrate intake, ingests alcohol without food, has inadequate 
or delayed meals, or loses weight while continuing the same medication regimen.  
Hypoglycemia can lead to very serious outcomes and the patient needs to be able to 
recognize the above actions that can lead to hypoglycemia as well as the symptoms and 
treatment of hypoglycemia.  Hypoglycemia constitutes a blood glucose level below 70 
mg/dL where the patient may experience increased sympathetic stimulation, headache, 
hunger, unsteadiness, altered vision, altered speech, seizures or coma.  Upon recognizing 
the symptoms of hypoglycemia, the patient should first sit down and ingest 15 to 20 
grams of carbohydrates.  Then after waiting at least 15 minutes to reassess blood sugar 
levels the patient should call a healthcare provider if these measures are inadequate to 
relieve symptoms (Michel, 2011).  
 Patients with T1D can experience a hyperglycemic condition called diabetic 
ketoacidosis (DKA).  DKA is characterized by hyperglycemia, ketosis, and metabolic 
acidosis (Guven et al., 2009).  In cases where there is a complete absence of insulin in the 
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blood, the body turns to fat tissue for energy because the cells are starved of glucose 
(Michel, 2011).  Lipolysis generates ketone byproducts that increase the acidity of the 
blood while blood glucose levels raise unopposed (Michel, 2011).  Insulin deficiency also 
leaves glucagon uninhibited which allows for the dysregulation of glycogenolysis and 
gluconeogenesis, further increasing blood glucose levels and protein degradation 
(Brashers & Jones, 2010).   
 DKA can develop rapidly and lead to life threatening fluid imbalances.  
Emergency medical treatment includes intravenous (IV) access with carefully monitored 
fluid and electrolyte replacement.  Fluid administration must be slow and closely 
monitored due to the potential of rapid fluid shifts to cause cerebral edema (Michel, 
2011).    
 
Long-Term Complications 
 Uncontrolled blood glucose levels lead to long-term complications in patients 
with T1D (The Diabetes Control, 1993).  Patients who do not continue to have 
educational support for the management of their diabetes are at a higher risk of 
developing chronic co-morbidities (Lange et al., 2014).  Even four to six years of 
diminished glycemic control during adolescence can permanently increase a patient’s risk 
of developing co-morbidities (Silverstein et al., 2005).  Poor glycemic control increases 
the risk of developing macrovascular damage, microvascular damage, and infection 
(Jones et al., 2010).     
 Macrovascular complications are more common in patients with type 2 diabetes 
but are still a risk for those with T1D.  Damage to the large and medium-sized vessels can 
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lead to conditions such as coronary artery disease, stroke, and peripheral artery disease 
(Jones et al., 2010).  Obesity, smoking, hypertension, a high-fat diet, and a sedentary 
lifestyle are factors that increase a patient’s risk for macrovascular complications and 
should be addressed by the healthcare provider (Michel, 2011). 
 The most common forms of microvascular damage include retinopathy, 
nephropathy, and neuropathy.  The increased risk of infection in diabetic patients is 
multifactorial: 1) impaired vision due to retinopathy diminishes a first-line defense 
mechanism to skin breaks, 2) oxygen release from hemoglobin in red blood cells is more 
difficult when HgbA1c levels increase, 3) microvascular and macrovascular changes 
diminish oxygen delivery and white blood cell availability, 4) the white blood cells that 
are available are functionally altered by ischemia and hyperglycemia, 5) pathogen 
proliferation may be enhanced due to the increased availability of glucose as a fuel 
source, 6) the inflammatory response to pathogens is lessened and signs and symptoms of 
infection may be unnoticed, and 7) the neuropathy of diabetes decreases the ability to 
sense injury and infection (Jones et al., 2010).   
 Vessel damage is theorized to proceed through several mechanisms.  Glucose 
metabolism for some tissues occurs via the polyol pathway.  Glucose is shunted to the 
polyol pathway when the blood is hyperglycemic and is converted to sorbitol.  Slowly, 
the sorbitol is converted to fructose, and the increased concentrations of both molecules 
pulls water into the vessels and out of the cells, predisposing them to injury.  Sorbitol 
affects nerves by altering ion pumps, Schwann cells, and nerve conduction.  Sorbitol also 
leads to swelling red blood cells and eye lenses.  Hyperglycemia causes untimely 
activation of protein kinase C (PKC) in various tissues.  PKC activation causes insulin 
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resistance, cytokine production, rapid reproduction of vessel cells, intensified 
contractility, and enhanced permeability.  The effect of inappropriately activated PKC is 
linked to macrovascular, microvascular and neurologic complications.  Chronic 
hyperglycemia also shunts excess intracellular glucose into the hexosamine pathway 
which results in complications of insulin resistance and cardiovascular damage (Jones et 
al., 2010).   
 Persistent hyperglycemia further damages vessels when glucose becomes attached 
to proteins, lipids, and nucleic acids in a phenomenon called nonenzymatic glycosylation.  
Specifically, glucose binds to vessel walls, interstitial tissue, and red blood cell proteins.  
It is the byproducts of glycosylation that are harmful.  Based on the properties of these 
byproducts, injury may be caused by the following mechanisms: 1) thickening of the 
basement membrane of vessels and protein trapping in the membrane; 2) increased 
permeability of blood vessels and nerves; 3) release of cytokines and growth factors in 
the glomeruli and vascular smooth muscle, 4) triggering of lipid oxidation, oxidative 
stress, and inflammation; 5) nitric oxide inactivation; and 6) increased coagulation in the 
endothelium.  Reactive oxygen species are more prevalent when blood sugar is 
chronically elevated; oxidative stress contributes to cellular injury as well as the 
development of gene products that secondarily induce cellular harm (Jones et al., 2010).   
Patient Education 
 T1D affects daily life and entails complex management.  Management of this 
disease is best accomplished when the adolescent takes responsibility for his or her own 
care (Clement, 1995; Michel, 2011).  According to Michel (2011), “Patients who actively 
manage their diabetes care have better outcomes than those who do not” (p. 1240).  
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Clement (1995) defined diabetes self-management education as “the process of providing 
the person with diabetes with the knowledge and skills needed to perform self-care, 
manage crises, and make lifestyle changes required to successfully manage the disease” 
(p. 1204).  The goal of diabetes education is for the patient to be empowered to be highly 
knowledgeable and the most active participant in his or her own healthcare (Clement, 
1995).    
Emergent Education Needs 
 At diagnosis, the patient will need to have an understanding of the basic survival 
skills until more comprehensive understanding can be developed (Lange et al., 2014).  It 
is important to have a parent or legal guardian present because much of the self-care 
activities and information will have to be taught to the patient at home, requiring the 
parent to ensure adherence to the diabetes regimen during the early stages of the disease 
(Jaacks et al., 2014).  Knowledge of adolescent development and learning abilities will 
enhance the provider’s communication with the patient as well as contribute to better 
patient understanding and adherence to the teaching (Coffen & Dahlquist, 2009).  It is 
important to explain the diagnosis to the adolescent and to assuage any feelings of guilt 
or regret by affirming that the patient did not do anything to cause T1D.  The patient will 
need to integrate the use of insulin into daily life immediately.  Explaining the digestion 
of carbohydrates and functions of insulin will help the patient understand why insulin is 
needed at so frequently throughout the day.  Thus, education regarding the disease 
process of T1D is beneficial and provides a basis for understanding of the treatments and 
complications related to diabetes (Lange et al., 2014). 
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 The initial diabetes education must also serve to build up a basic skill set in the 
patient because the patient is the most effective regulator of his or her body.  Blood 
glucose monitoring and insulin injection techniques are the most important skills 
involved in diabetes self-care.  Knowledge regarding the relationship of blood glucose 
levels and insulin administration should be addressed during this portion of the 
educational process.  The patient should be educated on sources of carbohydrates and 
carbohydrate counting to quantify insulin administration (Lange et al., 2014).   
 After the basics of self-care are addressed, the healthcare provider should explain 
the detriments of uncontrolled blood sugar.  Patients with T1D need to understand their 
physiological needs and be able to recognize the signs of hypoglycemia and 
hyperglycemia.  This understanding will develop over time; however, in the beginning 
the provider should help the patient think through the triggers of hypoglycemia and 
hyperglycemia.  Dietary choices, exercise, hormonal influences, insulin administration 
levels, peer pressure, and feelings of shame or embarrassment can all lead to a deviation 
in a patient’s normal blood glucose levels.  The patient should be taught to consider the 
circumstances in which these adverse effects occur, along with the accompanying signs 
and symptoms, treatment, management, and prevention of abnormal blood glucose levels.  
The goal is for the patient to be informed and empowered to respond to his or her own 
body and to maintain a healthy lifestyle (Lange et al., 2014).   
 The initial treatment concludes by addressing the use of medical alert 
identification accessories, available diabetes support services, home and school diabetes 
management, psychological adjustment, emergency contacts, and integration of the self-
care activities into the patient’s everyday life.  The provider should stress the importance 
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of continuing care and form a plan for regular appointments with the patient.  Diabetes 
self-management is an enormous task for any person, and not all the information and 
teaching can be effectively received by an adolescent during the initial visit.  Ongoing 
education is necessary for successful outcomes as the patient will encounter new 
experiences and individual problems with this disease (Lange et al., 2014). 
 Initial and continuing education involve life-changing tasks that the pediatric 
patient must put into practice to be healthy. Success is not likely to be obtained if the 
adolescent patient is responsible for the totality of self-care and glycemic control.  Coffen 
and Dahlquist (2009) have proposed four implications of diabetes education with young 
patients.  First, diabetes education for adolescents requires a collaborative team approach 
to diabetes education, involving input from physical health professionals, mental health 
professionals, and diabetes educators in the effort to bring developmentally appropriate 
teaching to the patient.  These professionals must also be able to discern when the 
teaching is more appropriate for parents to receive if the adolescent is developmentally 
unable to handle the teaching (Coffen & Dahlquist, 2009).   
 Second, in recognition of the magnitude of the diabetes regimen, promoting 
adherence to a specific aspect of self-care is better than stressing compliance to the grand 
scheme of diabetes self-care.  Inviting in a whole new lifestyle is seemingly impossible to 
an adolescent patient.  An overwhelming feeling may lead the patient to lose hope and 
give up on trying to cope.  Instead of presenting an overall picture of diabetes self-
management “it may be best to maintain a realistic depth of detail in assessment but 
reduce the breadth of what one strives to evaluate at any one point in time” (Coffen & 
Dahlquist, 2009, p. 306).   
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 Third, interventions can be more focused and concise with implementation of 
detailed task analyses rather than analyses of every single aspect of patient adherence.  
Intervention programs often cover all facets of diabetes care without targeting the 
patient’s particular needs for intervention.  In this light, interventional efforts are more 
efficient when guided by knowledge of the patient’s specific behavior problems (Coffen 
& Dahlquist, 2009). 
 Finally, “Although the ultimate goal is for all youth with diabetes to be competent 
self-managers of their illness, the process of transferring control of the myriad self-
management tasks to the youth must be gradual (Coffen & Dahlquist, 2009, p. 306).  
Every young person can do something to care for his or her diabetes, however, educators 
should promote patient involvement in self-care rather than responsibility for self-care.  
The parent-adolescent team is the best approach to diabetes self-management when the 
parents gradually transfer responsibility for self-care tasks over to the adolescent at 
appropriate benchmarks (Coffen & Dahlquist, 2009). 
Continuing Education 
 After the initial diagnosis, the patient with T1D needs to continue to meet with 
healthcare providers on a regular basis in order to progress in self-care.  In these regular 
meetings, the patient should develop a deeper understanding of diabetes and metabolism.  
HgbA1c should be introduced and explained to the patient so that the patient understands 
how regimen adherence and long-term goals are assessed.  HgbA1c goals should be 
discussed during the primary care appointments that follow the initial diagnosis.  
Nutrition planning can be geared more toward the patient’s personal preferences and 
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realistic nutritional goals can be made as the patient discusses the regimen with the 
provider regularly (Lange et al., 2014).  
 The psychological issues that a patient with T1D may experience cannot be 
sufficiently addressed during the initial diagnosis.  As the patient continues to live with 
the disease new emotions and experiences will arise in the patient’s life and need to be 
discussed as they come.  Issues such as diabetic crises, hypoglycemia and glucagon 
treatment, and diabetes management during illness are all factors for which the patient 
will need to develop competencies.  Problem-solving in these situations is enhanced by 
previous education (Lange et al., 2014).   
 Adherence to the diabetes regimen is a difficult task for a person at any 
developmental level (Schiffrin, 2001).  Discussing the patient’s ambivalence and barriers 
to adherence is a pertinent intervention for adolescent patients (Trast, 2014).  Meeting 
with a trusted healthcare provider on a regular basis allows for identification of these 
barriers and provides support for patient-specific interventions.  Educating the patient 
about the long-term vascular complications of uncontrolled diabetes is an important 
motivational factor, but should be communicated in such a way that is not overwhelming 
for the patient (Lange et al., 2014).  
 Finally, continuing education serves as a platform for discussing areas of life that 
are affected by the patient’s diabetes.  Holidays and periods with less structure require the 
same nutritional vigilance and care as the structured times.  These times call for increased 
planning and foresight of the physical needs and psychosocial pressures that the 
adolescent will face.  The strict dietary needs can make traveling difficult for diabetics, 
and the healthcare provider should address the issues by gathering and assessing ideas 
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while the patient is in a safe environment.  Substance abuse, academic achievement, 
employment, driving privileges, sexuality and new research findings should also be 
brought into the ongoing patient-provider conversation as these issues will present unique 
challenges for the patient with T1D (Lange et al., 2014). 
 
Adolescent Development 
 In adolescence, a person begins to move from concrete operational thinking to 
formal operational thinking.  Their ideas are more adaptable and flexible and they are 
able to assimilate new information into their framework of life more easily than could a 
school-age child.  They can think about long-term scenarios more effectively and are able 
to consider paradoxes and inconsistencies and can make logical deductions based on 
facts.  Adolescents can think about abstract concepts such as love and hope, they can 
think about their own thinking and about the thoughts of others.  In fact, they are 
generally very concerned about the thoughts other people might have about them (Kollar, 
2013).  
 Adolescence is characterized psychosocially by a search for identity.  Insecurity is 
rampant among adolescents as their bodies change on the inside and their appearance is 
transformed.  The roles the adolescent played as a child no longer fit the perceived 
demands of his peer-group.  An adolescent is intensely concerned with social acceptance.  
He or she will do seemingly anything to achieve acceptance into a group.  In this 
endeavor, an adolescent seeks to find how his or her role fits with the fashions and values 
of his or her peers.  Developing personal values and integrating them with those of the 
society are important processes of adolescence (Franklin & Prows, 2013).   
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 Developmental changes during adolescence include profound physiologic 
changes that affect diabetes care.  The rapid growth and development that occur during 
puberty is linked to many changes, including an increase in growth hormone (GH) and 
insulin-like growth factor-1 (IGF-1) levels (Trast, 2014).  GH works to promote growth 
and development, increases blood glucose levels, and diminishes glucose utilization as a 
fuel source. GH secretion is doubled during puberty (Matfin, 2009).  GH and IGF-1 both 
lead to insulin resistance and, therefore, adolescent patients will need to administer more 
insulin than their younger and older counterparts (Trast, 2014).   
 The psychosocial aspects of adolescence predispose this age group to decreased 
glycemic control.  Adolescent patients with T1D are different from their peers at a time 
when they feel increased pressure to conform to social standards.  Body image stressors 
are often difficult for diabetic patients.  They must consciously and continuously manage 
the life sustaining actions of insulin, which their peers never have to consider.  At times, 
the intense desire for social acceptance may trump the motivation to care for basic 
physiologic needs because self-care activities may feel embarrassing and cause the 
adolescent to stand out in an undesirable way.  These psychosocial factors combined with 
a physiologic increase in counter-regulatory hormones require a developmentally 
appropriate intervention by healthcare professionals (Trast, 2014).   
Motivational Interviewing (MI) 
 Motivating an adolescent to prioritize diabetes self-care despite the strong 
tendencies to give in to competing social pressures must go beyond a simple transferring 
of knowledge from the healthcare provider to the patient.  According to Trast (2014), 
adolescents live healthier lives when their parents are supportive, care is individualized, 
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care includes psychosocial and psychological support, and their illnesses is not a major 
source of family strife.  MI is a behavioral change counseling method that is focused on 
helping patients surface their own desires to change rather than using pedagogical means 
to promote change.  In various clinical trials, patients who were exposed to MI were more 
likely than their counterparts to participate in their care, participate in follow-up visits, 
comply with glucose monitoring, maintain better glycemic control, and experience fewer 
adverse effects and hospitalizations (Rollnick et al., 2007).   
 MI is based on the premises that motivation for change can be developed within a 
therapeutic relationship and that people want to change but are often hindered by their 
own ambivalence.  For example, a 14-year old diabetic boy may have a habit of eating 
large amounts of candy with his friends when they are together.  He knows that this 
practice negatively effects blood sugar control, but to abstain would separate him from 
his peers and cause him to stand out in an undesirable way.  Unfortunately, these warring 
thoughts often leave a patient feeling bewildered and no change occurs (Rollnick et al., 
2007).  The MI intervention is fueled by the idea that “motivation for change is actually 
quite malleable and is particularly formed in the context of relationships” (Rollnick et al., 
2007, p. 6).   
 The technique of MI is described as being collaborative, evocative, and protective 
of patient autonomy.  These three characteristics make MI an appealing and effective 
technique in dealing with adolescent patients.  First, MI is a collaborative process in that 
it is conversational, a dialogue in which both sides influence the end result.  This 
collaboration allows for specificity and individualization of care.  It also allows the 
adolescent to feel respected and essential to the healthcare process because his or her 
DIABETES MANAGEMENT  25 
 
ideas are integral to the process.  The ability of the adolescent to exhibit formal thinking 
patterns enables the adolescent to recognize and discuss ambivalence to change.  
Secondly, MI is evocative.  Instead of telling the patient what to do, the goal is to elicit 
the healthy desires existing within the patient.  Drawing these out of the patient is more 
powerful than trying to persuade the patient to do what the provider wants.  The MI 
technique takes into account the idea that human nature intrinsically resists coercion.  
People want to be healthy, but their desires and efforts toward health are often buried 
under loads of fears and misconceptions about the demands of healthy living.  Thirdly, 
MI honors patient autonomy.  The technique hinges on the patient’s choice to change.  A 
healthcare provider cannot really make the patient do anything to promote health.  
Despite the risk of the patient making unhealthy choices, a technique free of coercion is 
an important factor in behavioral change.  These three MI characteristics are to permeate 
the environment of the conversation with the patient in need of behavioral change 
(Rollnick et al., 2007).   
 When MI is put into practice, the provider will turn away from reflexive 
correcting, seek out the patient’s intrinsic motivation factors, listen to the patient 
empathetically, and empower the patient to accomplish healthy change.  MI is 
accomplished through establishment of a therapeutic provider-patient relationship in 
which the provider resists the tendency to persuade the patient to do what the provider 
desires.  When a provider learns of an unhealthy pattern in the patient, it is natural for the 
provider to tell the patient that they should put a stop to the behavior.  Yet this “righting 
reflex” puts the patient on the defensive and does not allow the patient to explore his or 
her own desires to change (Rollnick et al., 2007, p. 7).  Rather, it brings forth the surge of 
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fears and ambivalence within the patient which leads the patient to resist change.  Instead, 
the provider will search out the patient’s motivational sources and desires.  In this 
exploration, the provider must practice good listening skills and exhibit empathy.  MI is 
built on the provider first being a learner and then guiding the patient to explore the 
findings (Rollnick et al., 2007).  In the words of Pascal (n.d.), “People are generally 
better persuaded by the reasons which they have themselves discovered than by those 
which have come into the mind of others” (para. 10).  Finally, the provider empowers the 
patient to implement the change that he or she already desires.  Therefore, the practice of 
MI is guided by these four principles of resisting, understanding, listening, and 
empowering (Rollnick et al., 2007).   
 It has been established that diabetics experience better glycemic control when 
they are the main proponents of their own healthcare (Michel, 2011).  MI is an excellent 
behavior change technique to use in the care of T1D patients transitioning into 
adolescence because it calls for an environment of patient empowerment and 
collaboration, which foster a positive identity formation (Rollnick et al., 2007).  As 
children enter into adolescence, they become more and more responsible for their own 
diabetes care and parental supervision tends to diminish.  Because of this, care should 
focus on building internal motivation rather than an external reward system (Naar-King 
& Ellis, 2011).  Clinical trials have found that exposure to MI positively correlates with 
increased utilization of healthcare, stronger commitment to blood glucose monitoring, 
and better glycemic control (Rollnick et al., 2007).   
 
 
DIABETES MANAGEMENT  27 
 
Conclusion 
 T1D is a life-threatening disease that necessitates drastic lifestyle demands.  
Adherence to the diabetes self-management regimen is important for both emergent and 
long-term health outcomes.  Adolescent patients face significantly different psychological 
and physical challenges to regimen adherence than do children and adults; therefore, 
patient education for diabetic adolescents must be tailored to the specific aspects of their 
development.  The healthcare professional’s role is to provide the patient with the 
necessary tools for managing care, both physical and psychological.  Describing the self-
care activities and lifestyle changes required for diabetes self-management is the first step 
in pursuing optimal clinical outcomes.  Helping the patient to walk through his or her 
ambivalence to change must then be addressed continuously.  MI is an effective 
behavioral change technique that empowers the patient to change by addressing 
developmental and personal barriers to change and promoting his or her intrinsic desire to 
achieve optimal health.  Because of the positive outcomes associated with utilizing MI in 
chronic diseases, MI should play a role in every adolescent’s T1D care.  
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